1/30/2026 CMS Announces Drugs Subject to IRA Negotiated Prices Starting in 2028

Please click on the link below:

CMS Announces Drugs Subject to IRA Negotiated Prices Starting in 2028

Powers will continue to monitor developments on IRA policies affecting covered entities. Please contact Powers’ drug pricing team, or your lead Powers attorney, if you have any questions.